144 related articles for article (PubMed ID: 29925004)
21. Selective inhibition of vascular endothelial growth factor receptor-2 (VEGFR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF.
Endo A; Fukuhara S; Masuda M; Ohmori T; Mochizuki N
J Recept Signal Transduct Res; 2003; 23(2-3):239-54. PubMed ID: 14626450
[TBL] [Abstract][Full Text] [Related]
22. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells.
Cai J; Ahmad S; Jiang WG; Huang J; Kontos CD; Boulton M; Ahmed A
Diabetes; 2003 Dec; 52(12):2959-68. PubMed ID: 14633857
[TBL] [Abstract][Full Text] [Related]
23. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.
Atzori MG; Tentori L; Ruffini F; Ceci C; Lisi L; Bonanno E; Scimeca M; Eskilsson E; Daubon T; Miletic H; Ricci Vitiani L; Pallini R; Navarra P; Bjerkvig R; D'Atri S; Lacal PM; Graziani G
J Exp Clin Cancer Res; 2017 Aug; 36(1):106. PubMed ID: 28797294
[TBL] [Abstract][Full Text] [Related]
24. A placental growth factor variant unable to recognize vascular endothelial growth factor (VEGF) receptor-1 inhibits VEGF-dependent tumor angiogenesis via heterodimerization.
Tarallo V; Vesci L; Capasso O; Esposito MT; Riccioni T; Pastore L; Orlandi A; Pisano C; De Falco S
Cancer Res; 2010 Mar; 70(5):1804-13. PubMed ID: 20145150
[TBL] [Abstract][Full Text] [Related]
25. Pathogenic CD8
Pham TT; Verheijen M; Vandermosten L; Deroost K; Knoops S; Van den Eynde K; Boon L; Janse CJ; Opdenakker G; Van den Steen PE
Front Cell Infect Microbiol; 2017; 7():416. PubMed ID: 29034214
[TBL] [Abstract][Full Text] [Related]
26. Involvement of placental growth factor upregulated via TGF-β1-ALK1-Smad1/5 signaling in prohaptoglobin-induced angiogenesis.
Oh MK; Kim IS
PLoS One; 2019; 14(4):e0216289. PubMed ID: 31034502
[TBL] [Abstract][Full Text] [Related]
27. Expression of placenta growth factor is regulated by both VEGF and hyperglycaemia via VEGFR-2.
Zhao B; Cai J; Boulton M
Microvasc Res; 2004 Nov; 68(3):239-46. PubMed ID: 15501243
[TBL] [Abstract][Full Text] [Related]
28. Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation.
Zheng Y; Murakami M; Takahashi H; Yamauchi M; Kiba A; Yamaguchi S; Yabana N; Alitalo K; Shibuya M
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2019-26. PubMed ID: 16794222
[TBL] [Abstract][Full Text] [Related]
29. Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A.
Nozaki M; Sakurai E; Raisler BJ; Baffi JZ; Witta J; Ogura Y; Brekken RA; Sage EH; Ambati BK; Ambati J
J Clin Invest; 2006 Feb; 116(2):422-9. PubMed ID: 16453023
[TBL] [Abstract][Full Text] [Related]
30. E2F1 suppresses cardiac neovascularization by down-regulating VEGF and PlGF expression.
Wu M; Zhou J; Cheng M; Boriboun C; Biyashev D; Wang H; Mackie A; Thorne T; Chou J; Wu Y; Chen Z; Liu Q; Yan H; Yang Y; Jie C; Tang YL; Zhao TC; Taylor RN; Kishore R; Losordo DW; Qin G
Cardiovasc Res; 2014 Dec; 104(3):412-22. PubMed ID: 25341896
[TBL] [Abstract][Full Text] [Related]
31. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
[TBL] [Abstract][Full Text] [Related]
32. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1.
Autiero M; Waltenberger J; Communi D; Kranz A; Moons L; Lambrechts D; Kroll J; Plaisance S; De Mol M; Bono F; Kliche S; Fellbrich G; Ballmer-Hofer K; Maglione D; Mayr-Beyrle U; Dewerchin M; Dombrowski S; Stanimirovic D; Van Hummelen P; Dehio C; Hicklin DJ; Persico G; Herbert JM; Communi D; Shibuya M; Collen D; Conway EM; Carmeliet P
Nat Med; 2003 Jul; 9(7):936-43. PubMed ID: 12796773
[TBL] [Abstract][Full Text] [Related]
33. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
34. Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice.
Malik AK; Baldwin ME; Peale F; Fuh G; Liang WC; Lowman H; Meng G; Ferrara N; Gerber HP
Blood; 2006 Jan; 107(2):550-7. PubMed ID: 16189273
[TBL] [Abstract][Full Text] [Related]
35. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth.
Yang X; Zhang Y; Yang Y; Lim S; Cao Z; Rak J; Cao Y
Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13932-7. PubMed ID: 23918367
[TBL] [Abstract][Full Text] [Related]
37. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism.
Pipp F; Heil M; Issbrücker K; Ziegelhoeffer T; Martin S; van den Heuvel J; Weich H; Fernandez B; Golomb G; Carmeliet P; Schaper W; Clauss M
Circ Res; 2003 Mar; 92(4):378-85. PubMed ID: 12600898
[TBL] [Abstract][Full Text] [Related]
38. The biflavonoid amentoflavone inhibits neovascularization preventing the activity of proangiogenic vascular endothelial growth factors.
Tarallo V; Lepore L; Marcellini M; Dal Piaz F; Tudisco L; Ponticelli S; Lund FW; Roepstorff P; Orlandi A; Pisano C; De Tommasi N; De Falco S
J Biol Chem; 2011 Jun; 286(22):19641-51. PubMed ID: 21471210
[TBL] [Abstract][Full Text] [Related]
39. Short PlGF-derived peptides bind VEGFR-1 and VEGFR-2 in vitro and on the surface of endothelial cells.
Caporale A; Martin AD; Capasso D; Focà G; Sandomenico A; D'Andrea LD; Grieco P; Ruvo M; Doti N
J Pept Sci; 2019 May; 25(5):e3146. PubMed ID: 30652389
[TBL] [Abstract][Full Text] [Related]
40. The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo.
Atzori MG; Tentori L; Ruffini F; Ceci C; Bonanno E; Scimeca M; Lacal PM; Graziani G
J Pharmacol Exp Ther; 2018 Jan; 364(1):77-86. PubMed ID: 29025978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
